Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats

Behavioural Brain Research

Volumn 210, Issue 2, 2010, Pages 288-291

  Bruijnzeel, Adrie W ^a   Small, Elysia ^a   Pasek, Tim M ^a   Yamada, Hidetaka ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alcohol; Brain reward function; CRF; Dysphoria; ICSS; Rats; Withdrawal

Indexed keywords

ALCOHOL; ASTRESSIN; CORTICOTROPIN RELEASING FACTOR;

ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DYSPHORIA; MALE; NONHUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RAT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DISEASE MODELS, ANIMAL; ETHANOL; MALE; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 77952322172     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.02.043     Document Type: Article

References (26)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Press, Washington, DC.
2. Barr A.M., Markou A., Phillips A.G. A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 2002, 23:475-482.
3. Bruijnzeel A.W., Gold M.S. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res Brain Res Rev 2005, 49:505-528.
4. Bruijnzeel A.W., Prado M., Isaac S. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry 2009, 66:110-117.
5. Bruijnzeel A.W., Zislis G., Wilson C., Gold M.S. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 2007, 32:955-963.
6. Ciraulo D.A., Sands B.F., Shader R.I. Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 1988, 145:1501-1506.
7. De Bellis M.D., Gold P.W., Geracioti T.D., Listwak S.J., Kling M.A. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry 1993, 150:656-657.
8. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 2006, 26:11324-11332.
9. Griebel G., Simiand J., Steinberg R., Jung M., Gully D., Roger P., Geslin M., Scatton B., Maffrand J.P., Soubrie P. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4- methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J Pharmacol Exp Ther 2002, 301:333-345.
10. Hall W., Zador D. The alcohol withdrawal syndrome. Lancet 1997, 349:1897-1900.
11. Heilig M., Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 2007, 30:399-406.
12. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 1995, 6:74-80.
13. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
14. Kornetsky C., Esposito R.U. Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 1979, 38:2473-2476.
15. Lieber C.S., DeCarli L.M. Alcoholic liver injury: experimental models in rats and baboons. Adv Exp Med Biol 1975, 59:379-393.
16. Marcinkiewcz C.A., Prado M.M., Isaac S.K., Marshall A., Rylkova D., Bruijnzeel A.W. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 2009, 34:1743-1752.
17. Markou A., Koob G.F. Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 1992, 51:111-119.
18. McCarthy J.R., Heinrichs S.C., Grigoriadis D.E. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharm Des 1999, 5:289-315.
19. Merlo Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 1995, 15:5439-5447.
20. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
21. Olive M.F., Koenig H.N., Nannini M.A., Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 2002, 72:213-220.
22. Philibin S.D., Cameron A.J., Metten P., Crabbe J.C. Motor impairment: a new ethanol withdrawal phenotype in mice. Behav Pharmacol 2008, 19:604-614.
23. Rassnick S., Heinrichs S.C., Britton K.T., Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 1993, 605:25-32.
24. Rylkova D., Shah H.P., Small E., Bruijnzeel A.W. Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats. Psychopharmacology (Berl) 2009, 203:629-640.
25. Schulteis G., Markou A., Cole M., Koob G.F. Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 1995, 92:5880-5884.
26. Zislis G., Desai T.V., Prado M., Shah H.P., Bruijnzeel A.W. Effects of the CRF receptor antagonist d-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 2007, 58:958-966.